Paper32435751
Neisseria meningitidis: analysis of pili and LPS in emerging Brazilian strains.
Portilho AI and 2 others. Ther Adv Vaccines Immunother, 2020. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Neisseria meningitidis: analysis of pili and LPS in emerging Brazilian strains. Papers, record 32435751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32435751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2412271 | Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. | Rev Infect Dis | 1985 | https://conductscience.org/library/papers/2412271 | PubMed |
| 2 | 2107317 | Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. | J Med Microbiol | 1990 | https://conductscience.org/library/papers/2107317 | PubMed |
| 3 | 21679677 | Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. | Euro Surveill | 2011 | https://conductscience.org/library/papers/21679677 | PubMed |
| 4 | 17168996 | Molecular typing of meningococci: recommendations for target choice and nomenclature. | FEMS Microbiol Rev | 2007 | https://conductscience.org/library/papers/17168996 | PubMed |
| 5 | 21993636 | Neisseria meningitidis: biology, microbiology, and epidemiology. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/21993636 | PubMed |
| 6 | 18399938 | Type IV pili: e pluribus unum? | Mol Microbiol | 2008 | https://conductscience.org/library/papers/18399938 | PubMed |
| 7 | 20056121 | Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. | J Infect | 2010 | https://conductscience.org/library/papers/20056121 | PubMed |
| 8 | 29393729 | Challenges and opportunities for meningococcal vaccination in the developing world. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29393729 | PubMed |
| 9 | 30526162 | The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. | Expert Rev Vaccines | 2019 | https://conductscience.org/library/papers/30526162 | PubMed |
| 10 | 8627067 | A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8627067 | PubMed |
| 11 | 56416 | The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. | J Exp Med | 1976 | https://conductscience.org/library/papers/56416 | PubMed |
| 12 | 9887366 | Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). | Crit Rev Microbiol | 1998 | https://conductscience.org/library/papers/9887366 | PubMed |
| 13 | 15385499 | Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. | Infect Immun | 2004 | https://conductscience.org/library/papers/15385499 | PubMed |
| 14 | 15612917 | PilX, a pilus-associated protein essential for bacterial aggregation, is a key to pilus-facilitated attachment of Neisseria meningitidis to human cells. | Mol Microbiol | 2005 | https://conductscience.org/library/papers/15612917 | PubMed |
| 15 | 17604802 | Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. | Lancet | 2007 | https://conductscience.org/library/papers/17604802 | PubMed |
| 16 | 24966276 | Type IV pili-a numbers game. | EMBO J | 2014 | https://conductscience.org/library/papers/24966276 | PubMed |
| 17 | 7960107 | Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. | Infect Immun | 1994 | https://conductscience.org/library/papers/7960107 | PubMed |
| 18 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 19 | 30911127 | Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease. | Nat Microbiol | 2019 | https://conductscience.org/library/papers/30911127 | PubMed |
| 20 | 23382234 | Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23382234 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 35433054 | A Rare Cause of a Rare Disorder: E. coli-Induced Purpura Fulminans Secondary to Urinary Tract Infection. | Case Rep Crit Care | 2022 | https://conductscience.org/library/papers/35433054 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32435751
GET https://conductscience.org/api/papers/v1/32435751/references?page=2